TP53 and ovarian carcinoma: Evidence suggests that ovarian cancer cells can develop resistance by upregulating the ring finger protein 2, RNF2, an E3 ligase that targets the tumor suppressor p53 for degradation, thereby inhibiting cellular apoptosis (167).